Iproteos is selected for the semifinals of EIT Health’s prestigious European Health Catapult competition

You are here

42 start-ups chosen for the EIT Health European Health Catapult semifinals

The best biotech, medtech and digital health start-ups will compete to get to the finals at the EIT Health Summit in Paris

 

Following elimination rounds in all of EIT Health’s Regions, 42 start-ups have been named to compete in the semifinals of EIT Health’s prestigious European Health Catapult competition. The start-ups described below, offering innovative solutions for challenges ranging from cancer and chronic disease to medical imaging and precision diagnosis, must survive one more competition for a chance to go to the finals at the EIT Health Summit in Paris in December.



The European Health Catapult, which has been called one of the top competitions for biotech start-ups in Europe, is designed to identify and accelerate promising European start-ups in the categories of biotech, medtech and digital health. The regional candidate start-ups were screened by EIT Health regional representations – the EIT Co-location Centres (CLCs) and EIT Health InnoStars.

The 42 start-ups will receive intensive coaching on their value proposition and investor pitch, and then pitch competitively during the following semi-final events:

  • Biotech: Delft, Netherlands, 24-26 September 2019
  • Medtech: San Sebastian, Spain, 30 September-2 October 2019
  • Digital Health: London, UK, 8-10 October 2019

A jury will judge their presentations, their market readiness and the anticipated impact of their healthcare innovations, and half of them will be chosen to carry on in the competition. The 21 finalists will compete in the European Health Catapult Final in Paris, during the 2-3 December 2019 EIT Health Summit. The finalists will pitch their innovations to compete for recognition, the attention of investors and prizes worth a total of €210 000.